Cargando…
Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome
The five-year survival rate of lung cancer patients is very low, mainly because most newly diagnosed patients present with locally advanced or metastatic disease. Therefore, early diagnosis is key to the successful treatment and management of lung cancer. Unfortunately, early detection methods of lu...
Autores principales: | Haince, Jean-François, Joubert, Philippe, Bach, Horacio, Ahmed Bux, Rashid, Tappia, Paramjit S., Ramjiawan, Bram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835988/ https://www.ncbi.nlm.nih.gov/pubmed/35163138 http://dx.doi.org/10.3390/ijms23031215 |
Ejemplares similares
-
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
por: Singhal, Sandeep, et al.
Publicado: (2019) -
Biomarkers for Early Detection of Cancer: Molecular Aspects
por: Tappia, Paramjit S., et al.
Publicado: (2023) -
Use of amantadine in the evaluation of response to chemotherapy in lung cancer: a pilot study
por: Maksymiuk, Andrew W, et al.
Publicado: (2021) -
A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
por: Zhang, Lun, et al.
Publicado: (2020) -
Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer
por: Maksymiuk, Andrew W, et al.
Publicado: (2018)